Cargando…
Assay Challenges for Emerging Infectious Diseases: The Zika Experience
From the perspective of vaccine development, it is imperative to accurately diagnose target infections in order to exclude subjects with prior exposure from evaluations of vaccine effectiveness, to track incident infection during the course of a clinical trial and to differentiate immune reactions d...
Autores principales: | Roberts, Christine C., Maslow, Joel N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313918/ https://www.ncbi.nlm.nih.gov/pubmed/30279372 http://dx.doi.org/10.3390/vaccines6040070 |
Ejemplares similares
-
Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus
por: Maslow, Joel N.
Publicado: (2017) -
The cost and challenge of vaccine development for emerging and emergent infectious diseases
por: Maslow, Joel N
Publicado: (2018) -
Zika Vaccine Development—Current Progress and Challenges for the Future
por: Maslow, Joel N.
Publicado: (2019) -
Vaccine development for emerging virulent infectious diseases
por: Maslow, Joel N.
Publicado: (2017) -
The Forgotten Plague: Psychiatric Manifestations of Ebola, Zika, and Emerging Infectious Diseases
por: Tucci, Veronica, et al.
Publicado: (2017)